Journal
NATURE COMMUNICATIONS
Volume 7, Issue -, Pages -Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ncomms10918
Keywords
-
Categories
Funding
- European Research Council
- Swedish Research Council
- Strategic Research Area MultiPark (Multidisciplinary Research in Parkinson's disease) at Lund University
- Crafoord Foundation
- Swedish Brain Foundation
- Swedish Alzheimer foundation
- Torsten Soderberg Foundation at the Royal Swedish Academy of Sciences
- Knut and Alice Wallenberg Foundation
- Frimurarestiftelsen
- Swedish federal government under the ALF agreement
Ask authors/readers for more resources
Increased APP (amyloid precursor protein) processing causes beta-amyloid (Ab) accumulation in autosomal dominant Alzheimer's disease (AD), but it is unclear if it also affects sporadic A beta accumulation. We tested healthy controls and patients with mild cognitive symptoms (N = 331) in the BioFINDER study, using cerebrospinal fluid (CSF) A beta 40 as a surrogate for amyloidogenic APP processing. We find that levels of brain Ab fibrils (measured by 18F-flutemetamol PET) are independently associated with high CSF A beta 40 (P<0.001) and APOE epsilon 4 (P<0.001). The association between CSF A beta 40 and brain Ab is stronger in APOE epsilon 4-negative than in positive people (P = 0.0080). The results are similar for CSF A beta 38 and for a combination of CSF A beta 38 and CSF A beta 40. In conclusion, sporadic Ab accumulation may be partly associated with increased amyloidogenic APP production, especially in APOE epsilon 4-negative subjects. The risk for sporadic AD may consequently depend on increased Ab production, in addition to decreased A beta clearance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available